Stock 455 TIANDA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianda Pharmaceuticals Limited

Equities

455

KYG887471038

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 01:46:35 2024-04-18 am EDT 		5-day change 1st Jan Change
0.26 HKD +4.00% Intraday chart for Tianda Pharmaceuticals Limited +4.00% +19.27%
Mar. 26 Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 21 Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023 CI

Business Summary

Tianda Pharmaceuticals Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The Company operates businesses in Hong Kong, China and Australia.

Number of employees: 863

Sales per Business

HKD in Million2022Weight Delta
Pharmaceuticals and Medical Technologies
84.1 %
460 84.1 % -
Chinese Medicine
13.2 %
72 13.2 % -
Medical and Healthcare Services
2.7 %
15 2.7 % -

Sales per region

HKD in Million2022Weight Delta
China
98.4 %
538 98.4 % -
Hong Kong
1.4 %
8 1.4 % -
Australia
0.2 %
1 0.2 % -

Managers

Managers TitleAgeSince
Wen Quan Fang CEO
 Chief Executive Officer 55 02-12-31
Tai On Lo SEC
 Corporate Secretary 69 -

Members of the board

Members of the board TitleAgeSince
Sung Hong Chiu BRD
 Director/Board Member 77 08-04-09
Yat Fai Lam BRD
 Director/Board Member 58 03-12-31
Wen Quan Fang CEO
 Chief Executive Officer 55 02-12-31
Tao Zhong BRD
 Director/Board Member 52 23-08-28
Man Sang Lui BRD
 Director/Board Member 60 12-12-31
Quan Ming Feng BRD
 Director/Board Member 47 16-03-22
Xian Yanfang BRD
 Director/Board Member 43 23-06-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,150,041,884 442,328,526 ( 20.57 %) 0 20.57 %

Shareholders

NameEquities%Valuation
Wen Quan Fang
56.72 %
1,219,579,370 56.72 % 41 M $
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
13.05 %
280,517,724 13.05 % 9 M $
Government of China
9.656 %
207,616,264 9.656 % 7 M $

Company contact information

Tianda Pharmaceuticals Ltd.

CITIC Tower No. 1 Tim Mei Avenue, Central

, Hong Kong

+

http://www.tiandapharma.com
address Tianda Pharmaceuticals Limited(455)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
TIANDA PHARMACEUTICALS LIMITED Stock Tianda Pharmaceuticals Limited
+19.27% 68.64M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.79% 676B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.81% 554B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.64% 349B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.00% 318B
ABBVIE INC. Stock AbbVie Inc.
+5.99% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.47% 210B
NOVARTIS AG Stock Novartis AG
-0.02% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-9.98% 194B
PFIZER, INC. Stock Pfizer, Inc.
-11.71% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 455 Stock
  4. Company Tianda Pharmaceuticals Limited